Combined treatment with oral isoprinosine and intrathecal interferon alpha is considered to be the treatment of choice in subacute sclerosing panencephalitis (SSPE). We report the case of a 13-year-old SSPE patient who deteriorated over a 17-month period despite the early and continuous recommended treatment.
|Number of pages||3|
|Journal||Neurological Infections and Epidemology|
|State||Published - 1997|
- Subacute slerosing panencephalitis